Search details
1.
Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients.
Int J Mol Sci
; 25(7)2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38612790
2.
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy.
Int J Mol Sci
; 25(5)2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38473874
3.
Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients.
Int J Mol Sci
; 24(17)2023 Aug 27.
Article
in English
| MEDLINE | ID: mdl-37686099
4.
Ninety-day mortality and clinical outcomes of patients with solid tumours and COVID-19 infection during the first pandemic outbreak in Catalonia, Spain: A multicentre retrospective study.
Int J Cancer
; 150(8): 1310-1317, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-34921732
5.
Circulating leukocyte-platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents.
Cancer Immunol Immunother
; 70(6): 1691-1704, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33388994
6.
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
J Natl Compr Canc Netw
; : 1-9, 2021 Sep 24.
Article
in English
| MEDLINE | ID: mdl-34560672
7.
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.
Cancer
; 126(19): 4390-4399, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32697362
8.
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients.
Angiogenesis
; 22(3): 433-440, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30977010
9.
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
Br J Cancer
; 120(2): 190-195, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30585257
10.
Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.
Breast Cancer Res Treat
; 175(3): 733-740, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30887164
11.
Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis.
Breast Cancer Res Treat
; 167(1): 31-37, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28865009
12.
Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity.
Br J Clin Pharmacol
; 84(6): 1389-1392, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29504153
13.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Oncologist
; 22(11): 1301-1308, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28701571
14.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26786263
15.
Mammographic density and breast cancer in women from high risk families.
Breast Cancer Res
; 17: 93, 2015 Jul 11.
Article
in English
| MEDLINE | ID: mdl-26163143
16.
Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.
BMC Cancer
; 15: 460, 2015 Jun 09.
Article
in English
| MEDLINE | ID: mdl-26055977
17.
The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
Pharmacogenet Genomics
; 23(3): 142-7, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23324806
18.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
N Engl J Med
; 363(23): 2200-10, 2010 Dec 02.
Article
in English
| MEDLINE | ID: mdl-21121833
19.
Prehabilitation in Patients With Breast Cancer Receiving Neoadjuvant Therapy to Minimize Musculoskeletal Postoperative Complications and Enhance Recovery (PREOPtimize): A Protocol for a Randomized Controlled Trial.
Phys Ther
; 103(9)2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37318267
20.
Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis.
Clin Transl Oncol
; 25(4): 941-958, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36417083